Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

NCT00003880 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: recombinant adenovirus-p53 SCH-58500
DRUG: carboplatin
DRUG: paclitaxel

Sponsor

Merck Sharp & Dohme LLC